STOCK TITAN

Insider planned HRMY stock sale under Rule 144 with prior 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of HRMY has filed a Rule 144 notice to sell up to 20,961 shares of common stock, with an aggregate market value of 755,434.44. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/15/2026, and there were 57,596,358 shares of this class outstanding. The securities were acquired on 09/30/2025 as restricted stock units from the issuer.

Over the past three months, sales labeled as 10b5-1 sales for Sandip Kapadia included 20,000 common shares on 12/05/2025 for gross proceeds of 790,896.00 and 3,427 common shares on 11/21/2025 for gross proceeds of 119,945.00. The signer represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the HRMY Rule 144 filing disclose about planned share sales?

The notice discloses an intent to sell up to 20,961 shares of HRMY common stock with an aggregate market value of 755,434.44 through Morgan Stanley Smith Barney LLC on the NASDAQ around 01/15/2026.

How were the HRMY shares in this Rule 144 filing acquired?

The 20,961 common shares covered by the notice were acquired on 09/30/2025 as restricted stock units from the issuer, with the same date listed as the payment date and the nature of payment noted as N/A.

What prior HRMY stock sales are reported for the past three months?

The filing lists 10b5-1 sales for Sandip Kapadia: 20,000 common shares sold on 12/05/2025 for gross proceeds of 790,896.00, and 3,427 common shares sold on 11/21/2025 for gross proceeds of 119,945.00.

How many HRMY common shares are outstanding according to this notice?

The securities information section reports that there are 57,596,358 shares of the issuer’s common stock outstanding.

Which broker is handling the HRMY Rule 144 sale?

The planned sale is listed under Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the common stock.

What representation does the seller make in this HRMY Rule 144 filing?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Latest SEC Filings

HRMY Stock Data

2.10B
48.85M
11.04%
95.18%
7.53%
Biotechnology
Pharmaceutical Preparations
Link
United States
PLYMOUTH MEETING